シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 2,859,647株、対発行株数の割合は 3.75% です（2026-06-16公表時点、4機関が報告）。
空売り残高（合計）の推移
- Barclays Capital Securities
- GOLDMAN SACHS
- JPM Securities Japan Co
- Nomura
- UBS
- モルガン・スタンレーMUFG証券
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/04/30 | 2,897,880 | 3.88% (0.00%) |
| 2026/04/28 | 2,897,880 | 3.88% (-0.06%) |
| 2026/04/27 | 2,944,180 | 3.94% (-0.04%) |
| 2026/04/24 | 2,947,380 | 3.98% (-0.07%) |
| 2026/04/23 | 2,998,980 | 4.05% (+0.56%) |
| 2026/04/22 | 2,549,380 | 3.49% (+0.08%) |
| 2026/04/21 | 2,465,680 | 3.41% (+0.20%) |
| 2026/04/20 | 2,319,680 | 3.21% (-0.15%) |
| 2026/04/17 | 2,421,780 | 3.36% (-0.28%) |
| 2026/04/16 | 2,630,344 | 3.64% (-0.60%) |
| 2026/04/15 | 3,059,941 | 4.24% (-0.38%) |
| 2026/04/14 | 3,335,268 | 4.62% (-0.11%) |
| 2026/04/13 | 3,410,401 | 4.73% (+0.45%) |
| 2026/04/10 | 3,085,581 | 4.28% (-0.41%) |
| 2026/04/09 | 3,391,140 | 4.69% (-0.61%) |
| 2026/04/08 | 3,829,640 | 5.30% (-0.61%) |
| 2026/04/07 | 4,264,365 | 5.91% (0.00%) |
| 2026/04/06 | 4,264,365 | 5.91% (-0.27%) |
| 2026/04/03 | 4,462,603 | 6.18% (0.00%) |
| 2026/04/02 | 4,462,603 | 6.18% (-0.18%) |
| 2026/04/01 | 4,587,480 | 6.36% (-0.04%) |
| 2026/03/31 | 4,615,476 | 6.40% (-0.70%) |
| 2026/03/30 | 5,123,276 | 7.10% (-0.66%) |
| 2026/03/27 | 5,605,710 | 7.76% (-0.52%) |
| 2026/03/26 | 5,976,958 | 8.28% (+0.04%) |
| 2026/03/25 | 5,946,458 | 8.24% (-1.09%) |
| 2026/03/24 | 6,700,328 | 9.33% (-0.49%) |
| 2026/03/23 | 7,055,415 | 9.82% (-0.75%) |
| 2026/03/19 | 7,853,179 | 11.04% (-1.02%) |
| 2026/03/18 | 8,278,249 | 12.06% (-0.31%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全568件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| Barclays Capital Securities | 6/12 | 1,019,025 | 1.33% (+0.11%) |
| Barclays Capital Securities | 6/11 | 936,225 | 1.22% (+0.13%) |
| JPM Securities Japan Co | 6/11 | 560,951 | 0.73% (+0.09%) |
| Nomura | 6/11 | 464,467 | 0.60% (+0.06%) |
| Barclays Capital Securities | 6/10 | 832,925 | 1.09% (-0.01%) |
| Nomura | 6/10 | 418,839 | 0.54% (+0.15%) |
| Barclays Capital Securities | 6/9 | 840,125 | 1.10% (+0.15%) |
| Barclays Capital Securities | 6/8 | 726,825 | 0.95% (+0.17%) |
| Barclays Capital Securities | 6/5 | 599,025 | 0.78% (-0.11%) |
| Barclays Capital Securities | 6/4 | 686,025 | 0.89% (-0.12%) |
| Barclays Capital Securities | 6/3 | 772,725 | 1.01% (-0.16%) |
| Barclays Capital Securities | 6/2 | 895,325 | 1.17% (-0.09%) |
| Barclays Capital Securities | 6/1 | 957,325 | 1.26% (+0.13%) |
| Barclays Capital Securities | 5/29 | 853,725 | 1.13% (+0.17%) |
| Barclays Capital Securities | 5/28 | 729,025 | 0.96% (-0.14%) |
| JPM Securities Japan Co | 5/28 | 486,551 | 0.64% (+0.14%) |
| Barclays Capital Securities | 5/25 | 831,525 | 1.10% (+0.08%) |
| Barclays Capital Securities | 5/22 | 774,625 | 1.02% (+0.04%) |
| Barclays Capital Securities | 5/21 | 743,125 | 0.98% (-0.11%) |
| JPM Securities Japan Co | 5/21 | 378,451 | 0.50% (+0.01%) |
| JPM Securities Japan Co | 5/20 | 373,251 | 0.49% (-0.10%) |
| Barclays Capital Securities | 5/19 | 823,325 | 1.09% (-0.18%) |
| Barclays Capital Securities | 5/18 | 963,725 | 1.27% (-0.12%) |
| Barclays Capital Securities | 5/15 | 1,052,625 | 1.39% (-0.07%) |
| UBS | 5/14 | 354,300 | 0.46% (-0.04%) |
| Barclays Capital Securities | 5/12 | 1,102,225 | 1.46% (+0.13%) |
| UBS | 5/12 | 380,500 | 0.50% (+0.01%) |
| Barclays Capital Securities | 5/8 | 1,010,225 | 1.33% (-0.13%) |
| Barclays Capital Securities | 5/7 | 1,107,025 | 1.46% (-0.11%) |
| UBS | 5/7 | 371,100 | 0.49% (-0.04%) |